Exact Imaging Commended by Frost & Sullivan for ExactVu, its Micro-Ultrasound System for Targeted Prostate Biopsies - Seite 2
In addition, Exact Imaging's platform may be a superior clinical solution for image-guided, focused laser ablation (FLA) for urology by eliminating the need for costly and time-consuming MRI guidance during the procedure, thus making the treatment faster, more accurate, and cost effective. Exact Imaging's micro-ultrasound real-time imaging and biopsy guidance solution has the potential to dramatically increases the clinician's ability to target diseased tissue and receive superior guidance during the procedure, in terms of monitoring the FLA treatment.
"Its ease of use, accessible bedside biopsy for prostate cancer, and superior user experience for targeted biopsies can potentially attract a diverse customer base. To accelerate the commercialisation and growth of its technologies, Exact Imaging has secured key commercial partnerships, such as with UroGPO, a prominent urology-specific GPO in North America," noted Durga Chandrupatla. "These product benefits and expanded application scope can potentially position ExactVu as the standard of care in prostate cancer-targeted biopsies."
Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognises the solution's quality and the customer value enhancements it enables.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Exact Imaging
Exact Imaging (www.exactimaging.com) is the world's leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the
urological market for prostate cancer. Exact Imaging's ExactVu micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use,
affordability, and is an extension of the current urological workflow. Using the Exact Imaging platform, urologists are able to visualize areas of interest in the prostate and specifically target
biopsies at those areas. For those cases where MRI might assist, the FusionVu micro-US/MRI fusion application operates on the ExactVu micro-ultrasound platform and facilitates fast, simple
MRI fusion-based targeting with the guidance of the micro-ultrasound system's 70-micron real-time resolution. The ExactVu micro-ultrasound system including the FusionVu application has received
regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)), and Canada (Health Canada medical device
license).
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, collaborates with clients to leverage visionary innovation that addresses the global challenges and
related growth opportunities that will make or break today's market participants. For more than 50 years, Frost & Sullivan has been developing growth strategies for the global 1000, emerging
businesses, the public sector, and the investment community. Contact us: Start the discussion.
Contact:
Lesen Sie auch
Kristen Moore
P: 210.247.3823
E: kristen.moore@frost.com